News | Nuclear Imaging | May 10, 2016

MEDraysintell to Showcase Nuclear Imaging Reports at SNMMI 2016

Series of reports include nuclear medicine, cyclotrons, brachytherapy and proton therapy

Medraysintell, SNMMI 2016, nuclear imaging reports

May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) congress, June 11-15, in San Diego. The reports contain over 1,800 pages of intelligence covering nuclear medicine, cyclotrons, brachytherapy and proton therapy.

Nuclear Medicine World Market Report & Directory, Edition 2015 is a 930-page report and directory describing and analyzing over 335 radiopharmaceuticals and radionuclides, and more than 160 companies and institutions active in nuclear medicine.

Cyclotrons used in Nuclear Medicine, Edition 2015 is a 350-page report providing an extensive review of all cyclotrons around the world (over 1,200) with an exhaustive profile of the 14 companies active in this market.

The global brachytherapy industry is evaluated in a new and updated MEDraysintell report and directory, providing in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.

Proton Therapy world market report, Edition 2015 is the most comprehensive evaluation of the world proton therapy industry. This report includes a complete market review and contains a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.

MEDraysintell reports and directories can be customized to specific areas or modalities. Sample pages and complete table of contents are available upon request.

For more information:

Related Content

Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...